User-agent: Twitterbot/1.0
Allow: /programs/neurofrontiers/improving-the-early-detection-of-tk2d-with-genetic-testing/15890
Allow: /programs/neurofrontiers/cases-in-tk2d-care-lessons-learned-in-diagnosing-and-managing-a-rare-disease/15891
Allow: /programs/neurofrontiers/respiratory-challenges-in-neuromuscular-disorders-a-look-at-symptoms-and-impacts/29867
Allow: /programs/neurofrontiers/navigating-neuromuscular-diseases-chest-guidelines-for-respiratory-care/29868
Allow: /programs/neurofrontiers/optimizing-neuromuscular-disease-care-how-to-assess-and-address-respiratory-risks/29869
Allow: /programs/neurofrontiers/respiratory-dysfunction-in-neuromuscular-disorders-evaluating-symptoms/29870
Allow: /programs/neurofrontiers/optimizing-tk2d-care-through-a-multidisciplinary-approach/29877
Allow: /programs/neurofrontiers/redefining-migraine-care-early-diagnosis-and-prevention-strategies/35900
Allow: /programs/neurofrontiers/american-headache-society-updates-on-diagnosing-and-treating-migraine/35901
Allow: /live-events/qa-test-live-broadcast-poll2/36476
Allow: /live-events/qa-parent-hybrid-live-event/48961
Allow: /live-events/qa-child1-virtual-hybrid-live-event/48963
Allow: /live-events/emerging-focus-in-naion-sharpening-diagnostic-precision-for-tomorrows-treatments/49221
Allow: /live-events/when-mild-matters-most-closing-clinical-gaps-in-early-symptomatic-ad/54689
Allow: /live-events/reimagining-alzheimers-care-the-advent-of-subcutaneous-administration-of-anti-amyloid-therapyan-impact-live-series/54702
Allow: /live-events/qa-hybrid-live-event-parent-2/56545
Allow: /live-events/qa-virtual-live-event-parent-2-child-1/56551
Allow: /live-events/qa-in-person-live-event-parent-2-child-2/56552
Allow: /live-events/reimagining-alzheimers-care-the-advent-of-subcutaneous-administration-of-anti-amyloid-therapyan-impact-live-series/57116
Allow: /live-events/qa-test-live-broadcast-1508/61150
Allow: /live-events/qa-removed-pre-registration-flow/67164
Allow: /live-events/qa-removed-pre-registration-flow-parent/67166
Allow: /live-events/qa-removed-pre-registration-flow-in-person/67167
Allow: /live-events/qatest-new-virtual-hybrid-event/70652
Allow: /live-events/advancing-treat-to-target-care-in-generalized-myasthenia-gravis-earlier-diagnosis-standardized-assessment-and-precision-use-of-fcrn-directed-therapy/84881
Allow: /live-events/qatest-in-person-with-simulcast-activity/85464
Sitemap: https://globalneurologacademy.org/sitemap.xml
User-agent: *
Disallow: /accounts/reset*
Disallow: /accounts/password_reset*
Disallow: /playlist/top
Disallow: /profiles
Disallow: /profiles/peers/in-common*
Allow: /profiles/*/*/biography/
Disallow: /messages/send_to*

Disallow: /segment/*/
Disallow: /programs/focus-on-public-health-policy/establishing-community-protocols-for-treating-adhd/3689
Disallow: /programs/focus-on-neurology-and-psychiatry/educational-accommodations-for-the-adhd-patient/4095
Disallow: /programs/focus-on-heart-health/cardiac-screening-for-children-prescribed-adhd-meds/4243
Disallow: /programs/focus-on-neurology-and-psychiatry/non-stimulant-options-for-adhd-patients/4383
Disallow: /programs/focus-on-neurology-and-psychiatry/research-on-genetic-traits-of-adhd/4403
Disallow: /programs/focus-on-neurology-and-psychiatry/cognitive-behavioral-therapy-in-adults-with-adhd/4404
Disallow: /programs/advances-in-long-term-care-medicine/caring-for-patients-with-parkinsons-in-long-term-care/5593
Disallow: /programs/advances-in-long-term-care-medicine/theatre-as-therapy-for-alzheimers-and-memory-loss/5895
Disallow: /programs/advances-in-long-term-care-medicine/early-detection-of-alzheimers-where-do-we-go-from-here/6015
Disallow: /programs/advances-in-long-term-care-medicine/focusing-on-comfort-in-caring-for-patients-with-dementia-and-alzheimers/6395
Disallow: /programs/updates-from-mayo-clinic/managing-the-side-effects-of-adhd-medications/6786
Disallow: /programs/neurofrontiers/improving-the-early-detection-of-tk2d-with-genetic-testing/15890
Disallow: /programs/neurofrontiers/cases-in-tk2d-care-lessons-learned-in-diagnosing-and-managing-a-rare-disease/15891
Disallow: /programs/neurofrontiers/respiratory-challenges-in-neuromuscular-disorders-a-look-at-symptoms-and-impacts/29867
Disallow: /programs/neurofrontiers/navigating-neuromuscular-diseases-chest-guidelines-for-respiratory-care/29868
Disallow: /programs/neurofrontiers/optimizing-neuromuscular-disease-care-how-to-assess-and-address-respiratory-risks/29869
Disallow: /programs/neurofrontiers/respiratory-dysfunction-in-neuromuscular-disorders-evaluating-symptoms/29870
Disallow: /programs/neurofrontiers/optimizing-tk2d-care-through-a-multidisciplinary-approach/29877
Disallow: /programs/neurofrontiers/redefining-migraine-care-early-diagnosis-and-prevention-strategies/35900
Disallow: /programs/neurofrontiers/american-headache-society-updates-on-diagnosing-and-treating-migraine/35901
Disallow: /live-events/qa-test-live-broadcast-poll2/36476
Disallow: /live-events/qa-parent-hybrid-live-event/48961
Disallow: /live-events/qa-child1-virtual-hybrid-live-event/48963
Disallow: /live-events/emerging-focus-in-naion-sharpening-diagnostic-precision-for-tomorrows-treatments/49221
Disallow: /live-events/emerging-focus-in-naion-sharpening-diagnostic-precision-for-tomorrows-treatments/54275
Disallow: /live-events/emerging-focus-in-naion-sharpening-diagnostic-precision-for-tomorrows-treatments/54276
Disallow: /live-events/when-mild-matters-most-closing-clinical-gaps-in-early-symptomatic-ad/54689
Disallow: /live-events/reimagining-alzheimers-care-the-advent-of-subcutaneous-administration-of-anti-amyloid-therapyan-impact-live-series/54702
Disallow: /live-events/when-mild-matters-most-closing-clinical-gaps-in-early-symptomatic-ad/54754
Disallow: /live-events/when-mild-matters-most-closing-clinical-gaps-in-early-symptomatic-ad/56353
Disallow: /live-events/qa-hybrid-live-event-parent-2/56545
Disallow: /live-events/qa-virtual-live-event-parent-2-child-1/56551
Disallow: /live-events/qa-in-person-live-event-parent-2-child-2/56552
Disallow: /live-events/advancing-treat-to-target-care-in-generalized-myasthenia-gravis-earlier-diagnosis-standardized-assessment-and-precision-use-of-fcrn-directed-therapy/56565
Disallow: /live-events/an-exclusive-peer-dinner-with-gil-i-wolfe-md-faan-discussing-advancing-treat-to-target-care-in-generalized-myasthenia-gravis/56668
Disallow: /live-events/an-exclusive-peer-dinner-with-prof-abigail-schwaede-md-discussing-advancing-treat-to-target-care-in-generalized-myasthenia-gravis/56669
Disallow: /live-events/advancing-treat-to-target-care-in-generalized-myasthenia-gravis-earlier-diagnosis-standardized-assessment-and-precision-use-of-fcrn-directed-therapy/56671
Disallow: /live-events/advancing-treat-to-target-care-in-generalized-myasthenia-gravis-earlier-diagnosis-standardized-assessment-and-precision-use-of-fcrn-directed-therapy/56673
Disallow: /live-events/reimagining-alzheimers-care-the-advent-of-subcutaneous-administration-of-anti-amyloid-therapyan-impact-live-series/57116
Disallow: /live-events/qa-test-live-broadcast-1508/61150
Disallow: /live-events/qa-removed-pre-registration-flow/67164
Disallow: /live-events/qa-removed-pre-registration-flow-parent/67166
Disallow: /live-events/qa-removed-pre-registration-flow-in-person/67167
Disallow: /live-events/qatest-new-virtual-hybrid-event/70652
Disallow: /live-events/advancing-treat-to-target-care-in-generalized-myasthenia-gravis-earlier-diagnosis-standardized-assessment-and-precision-use-of-fcrn-directed-therapy/84881
Disallow: /live-events/qatest-in-person-with-simulcast-activity/85464
Disallow: /programs/focus-on-disaster-medicine-and-preparedness
Disallow: /programs/villanova_health_summit
Disallow: /programs/your-career-in-healthcare
Disallow: /test-aws/qa-test-adding-subcategory
Disallow: /qa-test-add-category
Sitemap: https://globalneurologyacademy.org/sitemap.xml